September 9, 2025 - 18:06

ASCAP has added John Pershing as Senior Vice President and Chief Technology Officer, effective immediately. In his new role, Pershing will be instrumental in driving the organization's technological advancements and digital strategy. With a wealth of experience in the tech industry, he is expected to enhance ASCAP's capabilities in serving its members and adapting to the ever-evolving landscape of music rights management.
Pershing brings a strong background in technology development and innovation, having previously held leadership positions in various tech firms. His expertise in software engineering and digital transformation will be invaluable as ASCAP seeks to improve its services and streamline operations.
The decision to appoint Pershing comes at a time when the music industry is increasingly relying on technology to navigate challenges and seize new opportunities. ASCAP is committed to leveraging cutting-edge solutions to better support its members and ensure they receive fair compensation for their work.
Pershing expressed enthusiasm about joining ASCAP, highlighting his dedication to fostering a more efficient and responsive organization.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...